This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Prognosis/ Outcomes  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Adam M. Quinn, MD; Kimberly Brown, MD; Brian K. Bonish, MD, PhD; Jonathan Curry, MD; Kenneth B. Gordon, MD; James Sinacore, PhD; Richard Gamelli, MD; Brian J. Nickoloff, MD, PhD

Arch Dermatol. 2005;141:683-687.

Objective  To identify histologic criteria and prognostic significance in patients with toxic epidermal necrolysis (TEN), a frequently lethal disease that usually represents an adverse drug reaction.

Design  Retrospective analysis of clinical records and histologic material from a 10-year period (1994-2004). Two investigators blinded to clinical data reviewed hematoxylin-eosin–stained sections.

Setting  North American tertiary care, university-based burn unit.

Patients  Thirty-seven patients treated for TEN between 1994 and 2004 who had sloughing of 30% or more of their total body surface area and who underwent skin punch biopsies immediately following admission.

Main Outcome Measure  The degree of dermal mononuclear (DM) inflammation was graded (sparse, moderate, or extensive) at least 2 high-power fields (HPF) away from the perimeter of epidermal detachment, and the mean number of DM cells/5 HPF was quantified for each patient. Clinical records were reviewed and the following data extracted: age, history of cancer, percentage of total body surface area slough, heart rate, and serum glucose, bicarbonate, and serum urea nitrogen values on admission. Severity scores for TEN (SCORTEN) were calculated, and clinical outcome was recorded as survived or died during hospitalization.

Results  Extent of inflammation was assessed by categorizing the mean ± SD DM cell counts as follows: sparse, 161 ± 36 cells/HPF (n = 15); moderate, 273 ± 76 cells/HPF (n = 15); and extensive, 392 ± 124 cells/HPF (n = 7). There was good concordance between observer ratings (P<.001). While 73% of patients (n = 11) with sparse inflammation survived, only 47% (n = 7) with moderate and 29% (n = 2) with extensive inflammation survived. The accuracy in predicting patient outcome was 65% using grade of inflammation, 68% with mean cell count, and 71% with SCORTEN.

Conclusions  There is a histologic spectrum with TEN that ranges from sparse to extensive DM inflammation, and degree of inflammation predicts clinical outcome approximately as well as SCORTEN. Future clinical trials should consider the possibility that various patient subsets exist within the TEN population, and a role for immunocytes needs to be critically reevaluated in this devastating disease.

Author Affiliations: Departments of Pathology (Drs Quinn, Bonish, Curry, and Nickoloff), Surgery (Drs Brown and Gamelli), Internal Medicine (Dr Gordon), and Preventive Medicine and Epidemiology (Dr Sinacore), Loyola University, Maywood, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Cell-Mediated Immunologic Mechanism and Severity of TEN
Ousmane Faye, Janine Wechsler, and Jean-Claude Roujeau
Arch Dermatol. 2005;141(6):775-776.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Consideration of Statistical Association
Adams
Arch Dermatol 2005;141:1604-1604.
FULL TEXT  

A Consideration of Statistical Association--Reply
Sinacore et al.
Arch Dermatol 2005;141:1604-1605.
FULL TEXT  

Factors of TEN
Journal Watch Dermatology 2005;2005:2-2.
FULL TEXT  

Cell-Mediated Immunologic Mechanism and Severity of TEN
Faye et al.
Arch Dermatol 2005;141:775-776.
FULL TEXT